BSE
Your Result on : Company News
Sun Pharmaceutical Industries Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524715
ISIN Demat
INE044A01036
Book Value (Rs)
93.2373503
NSE Symbol
SUNPHARMA
Divident Yield %
0.91
Market Cap
(Rs In Cr.)
422,427
P/E (TTM)
132.68
EPS (TTM)
13.27
Face Value
(Rs)
1
Date Heading
15-Oct-26 Sun Pharmaceuticals Industries announces board meeting date
13-Oct-26 Sun Pharma receives ratings action from ICRA
13-Oct-26 Sun Pharma receives affirmation in credit ratings from CRISIL
08-Oct-26 Sun Pharmaceuticals Industries to convene board meeting
28-Sep-26 Sun Pharma signs exclusive licensing agreement with LIB Therapeutics I
09-Sep-26 Sun Pharmaceutical Industries Ltd drops for fifth straight session
09-Sep-26 Sun Pharma incorporates subsidiary in IFSC, Gift City
17-Aug-26 Sun Pharma update on Lipitor antitrust litigation in US court
17-Aug-26 Sun Pharma receives favorable court ruling in Lipitor patent settlemen
05-Aug-26 Sun Pharmaceutical Industries receives ratings action from CRISIL
31-Jul-26 Sun Pharmaceutical Industries consolidated net profit rises 27.04% in
31-Jul-26 Sun Pharma Q1 PAT climbs 27% YoY to Rs 2,895 cr; India business drives
31-Jul-26 Sun Pharmaceutical Industries Ltd spurts 1.6%, up for five straight se
24-Jul-26 Sun Pharma receives Organon shareholders approval for merger
15-Jul-26 Sun Pharma receives approval to market semaglutide injection in South
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)